Site icon OncologyTube

Highlights from MDS and Nonmalignant Hematology New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib

Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks Highlights from MDS and Nonmalignant Hematology New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib at MOASCs Spotlight On® Hematology in Huntington Beach.

Exit mobile version